远程医疗加强喘管理-统一提供者 (TEAM-UP) 计划对喘结果的影响:一项随机临床试验
Jill S Halterman1, Maria Fagnano1, Paul J Tremblay1
1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY.
The Journal of pediatrics
|October 25, 2025
概括
一个结合远程医疗和观察治疗的学校干预措施改善了儿童的喘控制. 这种方法增加了无症状的日子,并减少了持久性喘儿童的急诊次数.
科学领域:
- 儿科肺病学 儿科肺病学
- 医疗保健服务研究 医疗服务研究
- 数字健康数字健康
背景情况:
- 喘是儿童常见的慢性呼吸道疾病,通常需要持续管理.
- 中度至重度的持续性喘显著影响儿童的生活质量和医疗保健利用率.
- 缺乏服务的社区在获得一致的喘护理方面面临着独特的挑战.
研究的目的:
- 评估针对中度至重度持久性喘儿童的学校干预措施.
- 评估将远程医疗咨询与预防性喘药物的学校直接观察治疗 (DOT) 整合的影响.
- 优化喘管理,减少儿童群体的医疗保健使用.
主要方法:
- 一项随机对照试验,涉及326名年龄在4-12岁的患有控制不良喘的儿童.
- 干预组:远程医疗增强喘管理 - 统一提供者 (TEAM-UP) 每天以学校为基础的DOT和专家远程医疗访问.
- 控制组:加强通常的护理. 主要结局:每2周平均无症状日.
主要成果:
- TEAM-UP组的儿童经历了显著更多的无症状日 (平均差异:1.32天/2周).
- TEAM-UP干预与减少学校缺勤率 (OR:0.70) 和减少急诊室访问或因喘住院 (OR:0.54) 相关.
- 在干预组中观察到高参与专家访问 (84%) 和DOT (74%).
结论:
- TEAM-UP干预显著改善了儿童的喘症状控制.
- 这种模式有效地减少了医疗保健的使用,包括急诊和住院.
- 学校远程医疗与交通部结合,为服务不足社区的喘护理提供了一个有前途的战略.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.3K
相关概念视频
01:30Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722